• 充值
  • 帮助
搜期刊
主题
文献检索

Journal of Molecular Medicine PubMed SCIE CA JST 中科院3区 JCR:Q1
发文量 1,454
被引量 631
影响因子(2023) 1.000

The Journal of Molecular Medicine publishes original research articles and review articles that range from basic findings in mechanisms of disease pathogenesis to therapy. The focus includes all human diseases, including but not limited to: Aging, angiogenesis, autoimmune diseases as well as other inflammatory diseases, cancer, cardiovascular diseases, development and differentiation, endocrinology, gastrointestinal diseases and hepatology, genetics and epigenetics, hematology, hypoxia research, immunology, infectious diseases, metabolic disorders, neuroscience of diseases, -omics based disease research, regenerative medicine, and stem cell research. Studies solely based on cell lines will not be considered. Studies that are based on model organisms will be considered as long as they are directly relevant to human disease. J Mol Med is the continuation of the Berliner Klinische Wochenschrift (1864), one of the oldest and most prestigious European journals in which great scientists such as Paul Ehrlich, Robert Koch and Otto Warburg published their seminal, epoch-making discoveries.

  • 主办单位： SPRINGER HEIDELBERG
  • 出版地区： Germany
  • 出版周期： 月刊
  • 别名： 分子医学杂志
  • 国际标准连续出版物号： ISSN 0946-2716
  • 创刊时间： 1922年
  • 曾用名： Clinical investigator
热门主题：

PatientsPlasmaTherapyClinicalPatientBloodTreatmentRenalSerumEffectsReninSignificantEnzymeDiseaseDASHypertensionActivityProteinsReleaseALS

收录汇总 栏目浏览 期刊详情
收录汇总
出版文献
期刊详情
分析评价
  • 1
  • 2
  • 3
  • 4
  • 9
目录
封面
2024年11期
共：1篇

      不详

    • Spinella, FrancescaCaprara, ValentinaDi Castro, ValerianaRosanò, LauraCianfrocca, RobertaNatali, Pier GiorgioBagnato, Anna

2024年11期

2024年11期

客服咨询
投稿相关：023-63416211
撤稿相关：023-67396862
查重相关：023-63506028
重庆维普资讯有限公司 渝B2-20050021-1 渝公网备 50019002500403
违法和不良信息举报中心   举报邮箱：jubao@cqvip.com   互联网算法推荐专项举报：sfjubao@cqvip.com    网络暴力专项举报: bljubao@cqvip.com
网络出版：（署）网出证（渝）字第014号    出版物经营许可证：新出发2018批字第006号